<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03922698</url>
  </required_header>
  <id_info>
    <org_study_id>LMB06</org_study_id>
    <nct_id>NCT03922698</nct_id>
  </id_info>
  <brief_title>Potential Impact of Neuroimmune and Autophagic Alterations on the Progression and Severity of Human Atherosclerotic Process</brief_title>
  <official_title>Potential Impact of Neuroimmune and Autophagic Alterations on the Progression and Severity of Human Atherosclerotic Process</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Neuromed IRCCS</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Neuromed IRCCS</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The hypothesis of this study is that neural regulations of the atherosclerotic plaque,
      identified in the murine model of atherosclerosis, could also exist in human pathology. The
      dysregulation status of the autonomic nervous system is typical of several cardiovascular
      diseases, but the role it exerts in the modulation of important mechanisms at the basis of
      the atherosclerotic process progression has not been investigated yet. The main aim of this
      study will be to investigate, in the atherosclerotic plaque, the alterations of inflammatory
      and immune processes, the neural modulations and the presence of dysregulations of the
      autophagic process. The investigators will also associate the potential presence of neural
      modulations of the plaque to its stability/instability, from a clinical-translational point
      of view. Finally, the investigators aim at providing a solid basis for the development of
      novel therapeutic strategies, which could reduce the elevated health and welfare costs for
      the clinical management of cardiovascular pathologies such as atherosclerosis.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 1, 2019</start_date>
  <completion_date type="Anticipated">June 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Characterization of the neuro-modulation of immune system in atherosclerosis</measure>
    <time_frame>At enrollment</time_frame>
    <description>Immunohistochemistry and immunofluorescence of the autonomic nervous and immune systems in the atherosclerotic plaque, and flow cytometry analysis of circulating immune cells.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Characterization of the autophagic process and correlation with neural modulations of the stability/instability plaque</measure>
    <time_frame>At enrollment</time_frame>
    <description>Expression of autophagic markers and immunohistochemical analysis of the atherosclerotic plaque.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Carotid Atherosclerosis</condition>
  <arm_group>
    <arm_group_label>Case Group</arm_group_label>
    <description>Patients who undergo surgical intervention of carotid trombo-endo-arterectomy at the Department of Vascular Surgery of the IRCCS Neuromed, with specific inclusion/exclusion criteria</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No interventions</intervention_name>
    <description>No interventions - observational study</description>
    <arm_group_label>Case Group</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Whole blood and serum, bioptic tissue (atherosclerotic plaque)
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects will be selected from patients who will undergo to surgical intervention of
        carotid trombo-endo-arterectomy at the Department of Vascular Surgery of the IRCCS
        Neuromed, accordingly to the following inclusion/exclusion criteria. Approximately 50
        subjects of both genders will be included in the study.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age ≥ 45 and ≤ 90 years;

          -  patients with severe (70-99%) carotid stenosis, diagnosed with color doppler
             echography or angio-MRI or angiography;

          -  written informed consent.

        Exclusion Criteria:

          -  carotid stenosis &lt;70% at carotid bifurcation or diagnosed with color doppler
             echography or angio-MRI or angiography;

          -  severe neoplasia;

          -  participation to other clinical trial, ongoing or terminated less than one month
             before enrolment in this study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Giuseppe Lembo, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>IRCCS Neuromed</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Giacomo Frati, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>IRCCS Neuromed</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Giuseppe Lembo, MD, PhD</last_name>
    <phone>+39 0865915225</phone>
    <email>lembo@neuromed.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>IRCCS Neuromed</name>
      <address>
        <city>Pozzilli</city>
        <zip>86077</zip>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Giuseppe Lembo, MD, PhD</last_name>
      <phone>+39 0865915225</phone>
    </contact>
    <investigator>
      <last_name>Giuseppe Lembo, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Giacomo Frati, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Daniela Carnevale, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Francesco Pompeo, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alessandro Landolfi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>April 17, 2019</study_first_submitted>
  <study_first_submitted_qc>April 17, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 22, 2019</study_first_posted>
  <last_update_submitted>April 17, 2019</last_update_submitted>
  <last_update_submitted_qc>April 17, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 22, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Neuromed IRCCS</investigator_affiliation>
    <investigator_full_name>Giuseppe Lembo</investigator_full_name>
    <investigator_title>Full Professor, MD, PhD</investigator_title>
  </responsible_party>
  <keyword>atherosclerotic plaque</keyword>
  <keyword>autonomic nervous system</keyword>
  <keyword>immune system</keyword>
  <keyword>autophagy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carotid Artery Diseases</mesh_term>
    <mesh_term>Atherosclerosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

